BioLineRx Reports Year-End 2020 Financial Results and Provides Corporate Update

TEL AVIV, Israel, /PRNewswire/ — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the year …